Quarterly report pursuant to Section 13 or 15(d)

Revenue Information (Tables)

v3.20.2
Revenue Information (Tables)
6 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Schedule of Revenue by Product Lines

Revenue by product lines was as follows:

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
Product Line   2020     2019     2020     2019  
MicroParticle Catalyzed Biosensor (“MPC”)   $ -     $ 65,344     $ -     $ 88,664  
Particle ImmunoFiltration Assay (“PIFA”)     (3,399 )     304,658       351,059       880,973  
Rapid Enzymatic Assay (“REA”)     -       85,000       -       85,000  
Other     1,511       9,511       10,568       21,997  
Total Revenue   $ (1,888 )   $ 464,513     $ 361,627     $ 1,076,634  
Schedule of Revenue by Geographic Area Determined Based On Location of Customers

The total revenue by geographic area determined based on the location of the customers was as follows:

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
Geographic Region   2020     2019     2020     2019  
United States   $ (1,888 )   $ 447,013     $ 361,627     $ 1,059,134  
Rest of World     -       17,500       -       17,500  
Total Revenue   $ (1,888 )   $ 464,513     $ 361,627     $ 1,076,634